Therapy with the SGLT2 inhibitor empagliflozin led to predominant reductions in each left ventricular conclude systolic and diastolic volumes in two fair randomized studies of…
Therapy with the SGLT2 inhibitor empagliflozin led to predominant reductions in each left ventricular conclude systolic and diastolic volumes in two fair randomized studies of…